Advanced colon cancer patients lived twice as long with a Pfizer combo therapy, trial finds
A combination drug treatment doubled survival time for patients with an aggressive form of colorectal cancer, according to late-stage trial data published Friday.
A combination drug treatment doubled survival time for patients with an aggressive form of colorectal cancer, according to late-stage trial data published Friday.
What's Your Reaction?
